Beihua Kong

4PUBLICATIONS
1CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Solid tumoursCancer geneticsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Mar 15, 2020
Correction to: Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer.

Huan Wu, Rongrong Li, Zhiwei Zhang

|Dec 31, 2019
Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer.

Huan Wu, Rongrong Li, Zhiwei Zhang

|Aug 15, 2019
BRCA mutation frequency and clinical features of ovarian cancer patients: A report from a Chinese study group.

Hualei Bu, Jingying Chen, Qingshui Li

|Aug 22, 2018
PCNA-associated factor P15PAF , targeted by FOXM1, predicts poor prognosis in high-grade serous ovarian cancer patients.

Chengjuan Jin, Zhaojian Liu, Yingwei Li

Pageof 1

Frequent Collaborators

1 joint publications

Zhaojian Liu